Hausenblas HA, Schoulda JA, Smoliga JM; Schoulda; Smoliga (19 de agosto de 2014). "Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis". Molecular nutrition & food research59 (1): 147–59. PMID25138371. doi:10.1002/mnfr.201400173.
Goldberg DM, Yan J, Soleas GJ; Yan; Soleas (February 2003). "Absorption of three wine-related polyphenols in three different matrices by healthy subjects". Clin. Biochem.36 (1): 79–87. PMID12554065. doi:10.1016/S0009-9120(02)00397-1.
Baur JA, Sinclair DA; Sinclair (June 2006). "Therapeutic potential of resveratrol: the in vivo evidence". Nature Reviews Drug Discovery5 (6): 493–506. PMID16732220. doi:10.1038/nrd2060.
Wenzel E, Somoza V; Somoza (May 2005). "Metabolism and bioavailability of trans-resveratrol". Mol Nutr Food Res49 (5): 472–81. PMID15779070. doi:10.1002/mnfr.200500010.
Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R; Sforza; Galaverna; Ghidini; Caporaso; Vescovi; Fogliano; Marchelli (May 2005). "Bioavailability of trans-resveratrol from red wine in humans". Mol Nutr Food Res49 (5): 495–504. PMID15830336. doi:10.1002/mnfr.200500002.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J; Argmann; Gerhart-Hines; Meziane; Lerin; Daussin; Messadeq; Milne; Lambert; Elliott; Geny; Laakso; Puigserver; Auwerx (December 2006). "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha". Cell127 (6): 1109–22. PMID17112576. doi:10.1016/j.cell.2006.11.013.
Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK; McDonagh; Heltweg; Hixon; Westman; Caldwell; Napper; Curtis; Distefano; Fields; Bedalov; Kennedy (April 2005). "Substrate-specific activation of sirtuins by resveratrol". J. Biol. Chem.280 (17): 17038–45. PMID15684413. doi:10.1074/jbc.M500655200.
Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M; Wu; Cumine; Kim; Lu; Atangan; Wang (December 2009). "Resveratrol is not a direct activator of SIRT1 enzyme activity". Chem Biol Drug Des74 (6): 619–24. PMID19843076. doi:10.1111/j.1747-0285.2009.00901.x.
Robb EL, Page MM, Wiens BE, Stuart JA; Page; Wiens; Stuart (March 2008). "Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD". Biochem. Biophys. Res. Commun.367 (2): 406–12. PMID18167310. doi:10.1016/j.bbrc.2007.12.138.
Leiro J, Arranz JA, Fraiz N, Sanmartín ML, Quezada E, Orallo F; Arranz; Fraiz; Sanmartín; Quezada; Orallo (February 2005). "Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling". Int. Immunopharmacol.5 (2): 393–406. PMID15652768. doi:10.1016/j.intimp.2004.10.006.
Chun YJ, Kim MY, Guengerich FP; Kim; Guengerich (August 1999). "Resveratrol is a selective human cytochrome P450 1A1 inhibitor". Biochem. Biophys. Res. Commun.262 (1): 20–4. PMID10448061. doi:10.1006/bbrc.1999.1152.
Schwarz D, Roots I; Roots (April 2003). "In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1". Biochem. Biophys. Res. Commun.303 (3): 902–7. PMID12670496. doi:10.1016/S0006-291X(03)00435-2.
Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellón EA; Pozo-Guisado; Alvarez-Barrientos; Fernandez-Salguero; Castellón (2007). "Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines". J. Androl.28 (2): 282–93. PMID17050787. doi:10.2164/jandrol.106.000968.
Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, Lin HY; Shih; Cao; Davis; Davis; Lin (August 2006). "Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells". Mol. Cancer Ther.5 (8): 2034–42. PMID16928824. doi:10.1158/1535-7163.MCT-06-0216.
Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N; Nihal; Fu; Jarrard; Ahmad (May 2006). "Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins". Mol. Cancer Ther.5 (5): 1335–41. PMID16731767. doi:10.1158/1535-7163.MCT-05-0526.
Cao Y, Fu ZD, Wang F, Liu HY, Han R; Fu; Wang; Liu; Han (June 2005). "Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants". J Asian Nat Prod Res7 (3): 205–13. PMID15621628. doi:10.1080/10286020410001690190.
Parker JA, Arango M, Abderrahmane S, Lambert E, Tourette C, Catoire H, Néri C; Arango; Abderrahmane; Lambert; Tourette; Catoire; Néri (April 2005). "Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons". Nat. Genet.37 (4): 349–50. PMID15793589. doi:10.1038/ng1534.
Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG; Naugle; Zhang; Bomser; Meszaros (March 2005). "Inhibition of cardiac fibroblast proliferation and myofibroblast differentiation by resveratrol". Am. J. Physiol. Heart Circ. Physiol.288 (3): H1131–8. PMID15498824. doi:10.1152/ajpheart.00763.2004.
Prossnitz, Eric R.; Barton, Matthias (2014). "Estrogen biology: New insights into GPER function and clinical opportunities". Molecular and Cellular Endocrinology389 (1-2): 71–83. ISSN0303-7207. doi:10.1016/j.mce.2014.02.002.
Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I; Rajendrasozhan; Caito; Yang; Megson; Rahman (March 2008). "Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells". Am. J. Physiol. Lung Cell Mol. Physiol.294 (3): L478–88. PMID18162601. doi:10.1152/ajplung.00361.2007.
Hausenblas HA, Schoulda JA, Smoliga JM; Schoulda; Smoliga (19 de agosto de 2014). "Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus-systematic review and meta-analysis". Molecular nutrition & food research59 (1): 147–59. PMID25138371. doi:10.1002/mnfr.201400173.
Goldberg DM, Yan J, Soleas GJ; Yan; Soleas (February 2003). "Absorption of three wine-related polyphenols in three different matrices by healthy subjects". Clin. Biochem.36 (1): 79–87. PMID12554065. doi:10.1016/S0009-9120(02)00397-1.
Baur JA, Sinclair DA; Sinclair (June 2006). "Therapeutic potential of resveratrol: the in vivo evidence". Nature Reviews Drug Discovery5 (6): 493–506. PMID16732220. doi:10.1038/nrd2060.
Wenzel E, Somoza V; Somoza (May 2005). "Metabolism and bioavailability of trans-resveratrol". Mol Nutr Food Res49 (5): 472–81. PMID15779070. doi:10.1002/mnfr.200500010.
Vitaglione P, Sforza S, Galaverna G, Ghidini C, Caporaso N, Vescovi PP, Fogliano V, Marchelli R; Sforza; Galaverna; Ghidini; Caporaso; Vescovi; Fogliano; Marchelli (May 2005). "Bioavailability of trans-resveratrol from red wine in humans". Mol Nutr Food Res49 (5): 495–504. PMID15830336. doi:10.1002/mnfr.200500002.
Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J; Argmann; Gerhart-Hines; Meziane; Lerin; Daussin; Messadeq; Milne; Lambert; Elliott; Geny; Laakso; Puigserver; Auwerx (December 2006). "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha". Cell127 (6): 1109–22. PMID17112576. doi:10.1016/j.cell.2006.11.013.
Kaeberlein M, McDonagh T, Heltweg B, Hixon J, Westman EA, Caldwell SD, Napper A, Curtis R, DiStefano PS, Fields S, Bedalov A, Kennedy BK; McDonagh; Heltweg; Hixon; Westman; Caldwell; Napper; Curtis; Distefano; Fields; Bedalov; Kennedy (April 2005). "Substrate-specific activation of sirtuins by resveratrol". J. Biol. Chem.280 (17): 17038–45. PMID15684413. doi:10.1074/jbc.M500655200.
Beher D, Wu J, Cumine S, Kim KW, Lu SC, Atangan L, Wang M; Wu; Cumine; Kim; Lu; Atangan; Wang (December 2009). "Resveratrol is not a direct activator of SIRT1 enzyme activity". Chem Biol Drug Des74 (6): 619–24. PMID19843076. doi:10.1111/j.1747-0285.2009.00901.x.
Robb EL, Page MM, Wiens BE, Stuart JA; Page; Wiens; Stuart (March 2008). "Molecular mechanisms of oxidative stress resistance induced by resveratrol: Specific and progressive induction of MnSOD". Biochem. Biophys. Res. Commun.367 (2): 406–12. PMID18167310. doi:10.1016/j.bbrc.2007.12.138.
Leiro J, Arranz JA, Fraiz N, Sanmartín ML, Quezada E, Orallo F; Arranz; Fraiz; Sanmartín; Quezada; Orallo (February 2005). "Effect of cis-resveratrol on genes involved in nuclear factor kappa B signaling". Int. Immunopharmacol.5 (2): 393–406. PMID15652768. doi:10.1016/j.intimp.2004.10.006.
Chun YJ, Kim MY, Guengerich FP; Kim; Guengerich (August 1999). "Resveratrol is a selective human cytochrome P450 1A1 inhibitor". Biochem. Biophys. Res. Commun.262 (1): 20–4. PMID10448061. doi:10.1006/bbrc.1999.1152.
Schwarz D, Roots I; Roots (April 2003). "In vitro assessment of inhibition by natural polyphenols of metabolic activation of procarcinogens by human CYP1A1". Biochem. Biophys. Res. Commun.303 (3): 902–7. PMID12670496. doi:10.1016/S0006-291X(03)00435-2.
Benitez DA, Pozo-Guisado E, Alvarez-Barrientos A, Fernandez-Salguero PM, Castellón EA; Pozo-Guisado; Alvarez-Barrientos; Fernandez-Salguero; Castellón (2007). "Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines". J. Androl.28 (2): 282–93. PMID17050787. doi:10.2164/jandrol.106.000968.
Tang HY, Shih A, Cao HJ, Davis FB, Davis PJ, Lin HY; Shih; Cao; Davis; Davis; Lin (August 2006). "Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells". Mol. Cancer Ther.5 (8): 2034–42. PMID16928824. doi:10.1158/1535-7163.MCT-06-0216.
Aziz MH, Nihal M, Fu VX, Jarrard DF, Ahmad N; Nihal; Fu; Jarrard; Ahmad (May 2006). "Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3'-kinase/Akt pathway and Bcl-2 family proteins". Mol. Cancer Ther.5 (5): 1335–41. PMID16731767. doi:10.1158/1535-7163.MCT-05-0526.
Cao Y, Fu ZD, Wang F, Liu HY, Han R; Fu; Wang; Liu; Han (June 2005). "Anti-angiogenic activity of resveratrol, a natural compound from medicinal plants". J Asian Nat Prod Res7 (3): 205–13. PMID15621628. doi:10.1080/10286020410001690190.
Kode A, Rajendrasozhan S, Caito S, Yang SR, Megson IL, Rahman I; Rajendrasozhan; Caito; Yang; Megson; Rahman (March 2008). "Resveratrol induces glutathione synthesis by activation of Nrf2 and protects against cigarette smoke-mediated oxidative stress in human lung epithelial cells". Am. J. Physiol. Lung Cell Mol. Physiol.294 (3): L478–88. PMID18162601. doi:10.1152/ajplung.00361.2007.
Prossnitz, Eric R.; Barton, Matthias (2014). "Estrogen biology: New insights into GPER function and clinical opportunities". Molecular and Cellular Endocrinology389 (1-2): 71–83. ISSN0303-7207. doi:10.1016/j.mce.2014.02.002.